GE HealthCare Debuts Genesis Enterprise Imaging Portfolio at HIMSS Conference

News
Article

Offering four key software-as-a-service features, the cloud-based enterprise imaging suite reportedly offers enhanced security and storage and facilitates streamlined radiology workflows.

Providing a new suite of cloud-based features to foster workflow efficiencies in radiology, GE HealthCare unveiled the new Genesis enterprise imaging portfolio at the Healthcare Information and Management Systems Society (HIMSS) 2025 conference.

Facilitating easier access, management and storage of images, GE HealthCare said the Genesis suite is comprised of four key software-as-a-solution (SAAS) features.

GE HealthCare Debuts Genesis Enterprise Imaging Portfolio at HIMSS Conference

Key benefits of the new Genesis enterprise imaging portfolio include enhanced vendor-neutral image archiving, AI-powered data migration and cloud-based storage management, according to GE HealthCare. (Image courtesy of Adobe Stock.)

The suite includes the Edge feature, which enables hybrid solutions that allow facilities to combine existing investments in imaging hardware and software with cloud-based privacy and security safeguards. Other benefits include enhanced vendor-neutral image archiving, AI-powered data migration and cloud-based storage management, according to GE HealthCare.

“With the launch of the Genesis portfolio, we will be providing cloud-enabled solutions that can help transform patient care through accessible, sharable, and secure imaging data while simultaneously improving clinical and operational efficiencies,” noted Scott Miller, the CEO of Enterprise Imaging Solutions at GE HealthCare.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Related Content
© 2025 MJH Life Sciences

All rights reserved.